Hospital Clínic de Barcelona

Translating ctDNA into cutaneous melanoma care: An international expert survey (2026) Geidel G, Fekade N, Raabe K, Smit DJ, Adam L, Heidrich I, Rünger A, et al. Journal article MYELOstudy: lymph node stage of aggressiveness in medullary thyroid cancer—a retrospective multi-center study analysis (2026) Papavramidis T, Chorti A, Bakkar S, Raffaelli M, Košec A, Hoang VT, Lim JY, et al. Journal article Clinical Trial Endpoints for Perianal Fistulizing Crohn's Disease (2026) Reinisch W, Atreya R, Rieder F, Jairath V, Rimola J, Peyrin-Biroulet L, Tozer P, et al. Journal article, Review article Tirbanibulin 1 % ointment: A narrative review of new data presented at the 11th World Congress of Melanoma in conjunction with 21st European Association of Dermato-Oncology Congress 2025 (2026) Ardigò M, Heppt MV, Aguado L, Borgia F, Broganelli P, Coronel Pérez IM, Dirschka TP, et al. Journal article, Review article Towards fair decentralized benchmarking of healthcare AI algorithms with the Federated Tumor Segmentation (FeTS) challenge (2025) Zenk M, Baid U, Pati S, Linardos A, Edwards B, Sheller M, Foley P, et al. Journal article An international consensus on the design of clinical trials for advanced combination treatment (ACT) in inflammatory bowel disease (2025) Solitano V, Hanžel J, Ma C, Battat R, Raine T, Siegmund B, Peyrin-Biroulet L, et al. Journal article Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease (2025) Jessen F, Arbizu J, Boada M, Balasa M, Bennys K, Boban M, Bürger K, et al. Journal article Expert recommendations to standardize transcriptomic analysis in inflammatory bowel disease clinical trials (2025) Linggi B, Azucena S, Steere B, Verstockt B, Alsoud D, Casero D, Mcgovern D, et al. Journal article Revidierte Klassifikation epileptischer Anfälle: Positionspapier der Internationalen Liga gegen Epilepsie (2025) Beniczky S, Trinka E, Wirrell E, Abdulla F, Al Baradie R, Alonso Vanegas M, Auvin S, et al. Journal article, Review article Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial (2025) Bergmann L, Albiges L, Ahrens M, Gross-Goupil M, Boleti E, Gravis G, Fléchon A, et al. Journal article